{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:21:32Z","timestamp":1793481692178,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["SBO-140028"],"award-info":[{"award-number":["SBO-140028"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2017-83815-R"],"award-info":[{"award-number":["SAF2017-83815-R"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2017-87349-R"],"award-info":[{"award-number":["SAF2017-87349-R"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["20152031"],"award-info":[{"award-number":["20152031"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017 SGR 1604"],"award-info":[{"award-number":["2017 SGR 1604"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PIE14\/00034"],"award-info":[{"award-number":["PIE14\/00034"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["ZIADK31117"],"award-info":[{"award-number":["ZIADK31117"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.phrs.2021.105731","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T03:18:09Z","timestamp":1624072689000},"page":"105731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Optical control of adenosine A3 receptor function in psoriasis"],"prefix":"10.1016","volume":"170","author":[{"given":"Marc","family":"L\u00f3pez-Cano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9886-3925","authenticated-orcid":false,"given":"Ingrid","family":"Filgaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest G.","family":"Nolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3104-3364","authenticated-orcid":false,"given":"Gisela","family":"Cabr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1126-4138","authenticated-orcid":false,"given":"Jordi","family":"Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip K.","family":"Tosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6502-5012","authenticated-orcid":false,"given":"Concepci\u00f3","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-3739","authenticated-orcid":false,"given":"Francisco","family":"Ciruela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2021.105731_bib1","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.phrs.2021.105731_bib2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/reum.2018.80718","article-title":"Psoriasis in special localizations","volume":"56","author":"Dopytalska","year":"2018","journal-title":"Reumatologia"},{"key":"10.1016\/j.phrs.2021.105731_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.phrs.2021.105731_bib4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrrheum.2010.157","article-title":"Psoriasis: what we have learned from mouse models","volume":"6","author":"Wagner","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105731_bib5","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.jid.2016.05.122","article-title":"The exonuclease Trex2 shapes psoriatic phenotype","volume":"136","author":"Manils","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.phrs.2021.105731_bib6","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/17512433.2018.1548277","article-title":"Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis","volume":"11","author":"Stiff","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105731_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/med.21456","article-title":"A3 adenosine receptors as modulators of inflammation: from medicinal chemistry to therapy","volume":"38","author":"Jacobson","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2021.105731_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1468-3083.2011.04078.x","article-title":"Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial","volume":"26","author":"David","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.phrs.2021.105731_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40257-016-0179-3","article-title":"Novel oral therapies for psoriasis and psoriatic arthritis","volume":"17","author":"Yiu","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.phrs.2021.105731_bib10","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2021.105731_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/ac9507653","article-title":"A photochemical procedure for determining reaction quantum efficiencies in systems with multicomponent inner filter absorbances","volume":"68","author":"Lees","year":"1996","journal-title":"Anal. Chem."},{"key":"10.1016\/j.phrs.2021.105731_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ejoc.200400441","article-title":"Photochromism of dithienylethenes containing fluorinated thiophene rings","volume":"2005","author":"Higashiguchi","year":"2005","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.phrs.2021.105731_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-12-418687-3.00018-5","article-title":"Transient mammalian cell transfection with polyethylenimine (PEI)","volume":"529","author":"Longo","year":"2013","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.phrs.2021.105731_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2018.05.033","article-title":"Remote control of movement disorders using a photoactive adenosine A2A receptor antagonist","volume":"283","author":"Taura","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2021.105731_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ilar.38.1.41","article-title":"Special report: the 1996 guide for the care and use of laboratory animals","volume":"38","author":"Clark","year":"1997","journal-title":"ILAR J."},{"key":"10.1016\/j.phrs.2021.105731_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.phrs.2021.105731_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11302-015-9459-2","article-title":"Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain","volume":"11","author":"Tosh","year":"2015","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.phrs.2021.105731_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1126\/science.1202793","article-title":"Structure of an agonist-bound human A2A adenosine receptor","volume":"332","author":"Xu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.phrs.2021.105731_bib19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1039\/c2pp05399c","article-title":"Applications of p-hydroxyphenacyl (pHP) and coumarin-4-ylmethyl photoremovable protecting groups","volume":"11","author":"Givens","year":"2012","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.phrs.2021.105731_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/cr300177k","article-title":"Photoremovable protecting groups in chemistry and biology: reaction mechanisms and efficacy","volume":"113","author":"Kl\u00e1n","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.phrs.2021.105731_bib21","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/acs.joc.9b02617","article-title":"Spacer-mediated control of coumarin uncaging for photocaged thymidine","volume":"85","author":"Tang","year":"2020","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.phrs.2021.105731_bib22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/acschembio.6b00999","article-title":"Control of an unusual photo-claisen rearrangement in coumarin caged tamoxifen through an extended spacer","volume":"12","author":"Wong","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.phrs.2021.105731_bib23","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1002\/cpim.71","article-title":"IL-23- and imiquimod-induced models of experimental psoriasis in mice","volume":"125","author":"Singh","year":"2019","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.phrs.2021.105731_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1346-8138.14112","article-title":"Mouse models of psoriasis and their relevance","volume":"45","author":"Nakajima","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.phrs.2021.105731_bib25","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.phrs.2021.105731_bib26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.drudis.2014.02.010","article-title":"Adenosine and inflammation: what\u2019s new on the horizon?","volume":"19","author":"Antonioli","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2021.105731_bib27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tips.2016.02.006","article-title":"Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?","volume":"37","author":"Borea","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2021.105731_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.phrs.2013.08.002","article-title":"A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes","volume":"76","author":"Gessi","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105731_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuint.2007.06.026","article-title":"Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity","volume":"52","author":"Cunha","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2021.105731_bib30","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.4049\/jimmunol.157.10.4634","article-title":"Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice","volume":"157","author":"Hask\u00f3","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2021.105731_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.bjp.0702040","article-title":"Suppression of macrophage inflammatory protein (MIP)-1\u03b1 production and collagen-induced arthritis by adenosine receptor agonists","volume":"125","author":"Szab\u00f3","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105731_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(98)00619-0","article-title":"An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-\u03b3 production and prevents lethality in endotoxemic mice","volume":"358","author":"Hask\u00f3","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105731_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0014-2999(03)01570-X","article-title":"The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5\u2032-N-methyluronamide, is protective in two murine models of colitis","volume":"466","author":"Mabley","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105731_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.drudis.2011.10.007","article-title":"Pharmacological and therapeutic effects of A3 adenosine receptor agonists","volume":"17","author":"Fishman","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2021.105731_bib35","first-page":"931","article-title":"Treatment of plaque-type psoriasis with oral CF101: data from a phase II\/III multicenter, randomized, controlled trial","volume":"15","author":"David","year":"2016","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.phrs.2021.105731_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/cancers13020187","article-title":"Namodenoson in advanced hepatocellular carcinoma and Child\u2013Pugh B cirrhosis: randomized placebo-controlled clinical trial","volume":"13","author":"Stemmer","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2021.105731_bib37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41586-018-0236-6","article-title":"Structure of the adenosine-bound human adenosine A1 receptor-Gi complex","volume":"558","author":"Draper-Joyce","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2021.105731_bib38","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.37175\/stemedicine.v1i3.43","article-title":"Optogenetics and photopharmacology in pain research and therapeutics","volume":"1","author":"Iseppon","year":"2020","journal-title":"STEMedicine"},{"issue":"18","key":"10.1016\/j.phrs.2021.105731_bib39","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.3390\/molecules25184102","article-title":"Role of photoactive phytocompounds in photodynamic therapy of cancer","volume":"25","author":"Muniyandi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2021.105731_bib40","doi-asserted-by":"crossref","first-page":"10710","DOI":"10.1021\/acs.chemrev.8b00037","article-title":"In vivo photopharmacology","volume":"118","author":"H\u00fcll","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.phrs.2021.105731_bib41","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.1002\/anie.201601931","article-title":"Emerging targets in photopharmacology","volume":"55","author":"Lerch","year":"2016","journal-title":"Angew. Chem."},{"key":"10.1016\/j.phrs.2021.105731_bib42","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4049\/jimmunol.1001001","article-title":"IL-23\u2013mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A","volume":"186","author":"Rizzo","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2021.105731_bib43","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/19420862.2015.1032491","article-title":"Selective targeting of the IL23 pathway: generation and characterization of a novel highaffinity humanized anti-IL23A antibody","volume":"7","author":"Singh","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.phrs.2021.105731_bib44","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/bph.13446","article-title":"Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics","volume":"173","author":"Janes","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105731_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2019.02.006","article-title":"Light-triggered release of photocaged therapeutics - where are we now?","volume":"298","author":"Silva","year":"2019","journal-title":"J. Control. Release"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:41:58Z","timestamp":1778794918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821003157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":45,"alternative-id":["S1043661821003157"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105731","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optical control of adenosine A3 receptor function in psoriasis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105731"}}